US EditionPublished • loading... • Updated
After blocked Mayne deal, Australia M&As set for higher reverse break fees
Summary by WTVB
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
After blocked Mayne deal, Australia M&As set for higher reverse break fees
By Scott Murdoch SYDNEY (Reuters) -Foreign bidders for Australian companies could be liable for higher reverse break fees if regulatory approval is not received, in the wake of the failed $434 million takeover of Mayne Pharma, lawyers said. Treasurer Jim Chalmers blocked the takeover last week of Mayne by reluctant U.S. suitor Cosette Pharmaceuticals on the grounds of it not being in the national interest. Cosette bid for Mayne in February but l…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
